ABIM - Infectious Disease
AeromonasMhydrophilaM-MAnswerMFoundMinMaquaticMenvironements
GNR
Tx:MdoxycyclineMplusMciprofloxacinMorMceftriaxone
SmallMpoxMexposureM-MAnswerMGiveMvaccineM(live)MwithinM7Mdays
UnlessMtheMpatientMisMseverelyMimmunodeficientM(withinM4MmonthsMofMboneMmarrowM
transplantation,MHIVMinfectionMwithMCD4McellMcountsM<50/µL,MorMsevereMcombinedMim
munodeficiency),MtheMvaccineMshouldMbeMgiven.
IfMcontraindicated,MgiveMimmunoglobin
TetanusMwithMwoundsM-MAnswerM.MIfMgivenMlessMthanM3MlifetimeMdosesM:
-McleanMwound:MtoxoidMinjection
-McrushMwound,Mdirt/feces,MpunctureMwound,MorMbulletM:MtoxoidMplusMIG
IfMgivenMatMleastM3MlifetimeMdoses:
-McleanMwound:MtoxoidMinjectionMifMlastMwasM>M10MyearsMago
-
McrushMwound,Mdirt/feces,MpunctureMwound,MorMbulletM:MToxoidMifMgivenM>5MyearsMa
go
DogMbiteM&MrabiesM-MAnswerMObserveMtheMdogMforM10Mdays
WhenMtoMgiveMabxMforMbitesM-MAnswerMALLMhumanMbites
Animal:Mimmunocompromised,MalwaysMtreatMtheMhandM(closeMtoMjoints),Msevere,Mcrush,
Medema
RabiesMppxM-MAnswerMImmediateMfor:Mbat,Mraccoon,Mfox,Mskunk
ObserveManimalMforM10Mdays:Mdogs,Mcats,Mferret
NoMppx:Mrodents
SyphilisMtxM-MAnswerMPCNM2.4MmilMuntilMx1
, EarlyMlatentM50,000MmilMunitsMPCNMx1
LateMlatentM50,000MmilMunitsMPCNMweeklyMx3Mweeks
NeurosyphilisM-MaqueousMPCNM18-24MmillionMunits/dayMIVM10-
14Mdays.MRepeatMCSFMq6MmonthsMuntilMnormal
DisseminatedMgonorrheaMtxM-MAnswerM1gMceftriaxoneMIVMdailyMxM7Mdays
CampylobacterMtxM-MAnswerM3MdaysMazithromycin
MACM-MAnswerMgetMforMinhaledMofMaerosolizedMwater
canMgetM"hotMtubMlung"MhypersensitivityMpneumonitis
posttransplantMlymphoproliferativeMdisorderM(PTLD)M-MAnswerM-
Mfever,Mpancytopenia,MgeneralizedMlymphadenopathy,MandMhepatosplenomegaly
-MriskMisMhigherMinMpatientsMwithMaMhistoryMofMpre-
existingMEBVMinfectionMtreatedMwithMlymphocyte-
depletingMagentsMandMinMthoseMreceivingMsirolimusMandMtacrolimusMcomparedMwithMtho
seMreceivingMmycophenolateMandMcyclosporine.M
-PTLDMcanMrangeMfromMaMbenignMmonoclonalMgammopathyMtoMaMmalignantMlymphoma.
-Mtx:MdecreaseMimmunosupression;MrituximabMorMchemo
PPDM>5mmMpositiveMifM-MAnswerMHIV
CloseMcontacts
PPDM>10mmMpositiveMifM-MAnswerMimmigrantMfromMendemicMarea
IVDA
HealthcareMemployeesM&Mresidents
AtMriskMforMTBMre-activation
ChagasMdiseaseM-MAnswerMPhaseM1:MfeversMandMarthalgias
PhaseM2:MNoMsymptoms
PhaseM3:Mcardiomyopathy.MLVMapicalManeurysmMisMpathognomonicMforMChagas
InMcentralM&MSouthMAmerica
AeromonasMhydrophilaM-MAnswerMFoundMinMaquaticMenvironements
GNR
Tx:MdoxycyclineMplusMciprofloxacinMorMceftriaxone
SmallMpoxMexposureM-MAnswerMGiveMvaccineM(live)MwithinM7Mdays
UnlessMtheMpatientMisMseverelyMimmunodeficientM(withinM4MmonthsMofMboneMmarrowM
transplantation,MHIVMinfectionMwithMCD4McellMcountsM<50/µL,MorMsevereMcombinedMim
munodeficiency),MtheMvaccineMshouldMbeMgiven.
IfMcontraindicated,MgiveMimmunoglobin
TetanusMwithMwoundsM-MAnswerM.MIfMgivenMlessMthanM3MlifetimeMdosesM:
-McleanMwound:MtoxoidMinjection
-McrushMwound,Mdirt/feces,MpunctureMwound,MorMbulletM:MtoxoidMplusMIG
IfMgivenMatMleastM3MlifetimeMdoses:
-McleanMwound:MtoxoidMinjectionMifMlastMwasM>M10MyearsMago
-
McrushMwound,Mdirt/feces,MpunctureMwound,MorMbulletM:MToxoidMifMgivenM>5MyearsMa
go
DogMbiteM&MrabiesM-MAnswerMObserveMtheMdogMforM10Mdays
WhenMtoMgiveMabxMforMbitesM-MAnswerMALLMhumanMbites
Animal:Mimmunocompromised,MalwaysMtreatMtheMhandM(closeMtoMjoints),Msevere,Mcrush,
Medema
RabiesMppxM-MAnswerMImmediateMfor:Mbat,Mraccoon,Mfox,Mskunk
ObserveManimalMforM10Mdays:Mdogs,Mcats,Mferret
NoMppx:Mrodents
SyphilisMtxM-MAnswerMPCNM2.4MmilMuntilMx1
, EarlyMlatentM50,000MmilMunitsMPCNMx1
LateMlatentM50,000MmilMunitsMPCNMweeklyMx3Mweeks
NeurosyphilisM-MaqueousMPCNM18-24MmillionMunits/dayMIVM10-
14Mdays.MRepeatMCSFMq6MmonthsMuntilMnormal
DisseminatedMgonorrheaMtxM-MAnswerM1gMceftriaxoneMIVMdailyMxM7Mdays
CampylobacterMtxM-MAnswerM3MdaysMazithromycin
MACM-MAnswerMgetMforMinhaledMofMaerosolizedMwater
canMgetM"hotMtubMlung"MhypersensitivityMpneumonitis
posttransplantMlymphoproliferativeMdisorderM(PTLD)M-MAnswerM-
Mfever,Mpancytopenia,MgeneralizedMlymphadenopathy,MandMhepatosplenomegaly
-MriskMisMhigherMinMpatientsMwithMaMhistoryMofMpre-
existingMEBVMinfectionMtreatedMwithMlymphocyte-
depletingMagentsMandMinMthoseMreceivingMsirolimusMandMtacrolimusMcomparedMwithMtho
seMreceivingMmycophenolateMandMcyclosporine.M
-PTLDMcanMrangeMfromMaMbenignMmonoclonalMgammopathyMtoMaMmalignantMlymphoma.
-Mtx:MdecreaseMimmunosupression;MrituximabMorMchemo
PPDM>5mmMpositiveMifM-MAnswerMHIV
CloseMcontacts
PPDM>10mmMpositiveMifM-MAnswerMimmigrantMfromMendemicMarea
IVDA
HealthcareMemployeesM&Mresidents
AtMriskMforMTBMre-activation
ChagasMdiseaseM-MAnswerMPhaseM1:MfeversMandMarthalgias
PhaseM2:MNoMsymptoms
PhaseM3:Mcardiomyopathy.MLVMapicalManeurysmMisMpathognomonicMforMChagas
InMcentralM&MSouthMAmerica
